Analyst Ranking
Top 2%
#105 out of 5540 analysts
Average Return
+13.53%
Win Rate
45%237 out of 525
Risk vs Reward
Poor
Good

Douglas Tsao's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+885.37%$33.55$330.59
2025-03-03 -
2026-03-02
Buy
Praxis Precision Medicines IncPRAX
+737.70%$38.06$318.83
2025-05-01 -
2026-04-30
Buy
Praxis Precision Medicines IncPRAX
+548.82%$47.79$310.07
2025-08-05 -
2026-08-04
Buy
Praxis Precision Medicines IncPRAX
+483.86%$53.85$314.41
2025-07-18 -
2026-07-17
Buy
Praxis Precision Medicines IncPRAX
+428.38%$14.55$76.88
2023-11-15 -
2024-11-14
Buy

Douglas Tsao Analyst Color

Get additional color on Douglas Tsao's coverage of popular stocks

Douglas Tsao's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Pacira Biosciences IncPCRX
5Hold$36.50+0.27%Downgrades
6 days ago
Praxis Precision Medicines IncPRAX
36Buy$1,201.00+402.47%Reiterates
9 days ago
Rezolute IncRZLT
21Buy$10.00+136.41%Maintains
20 days ago
Biohaven LtdBHVN
15Hold$10.00-8.51%Reiterates
a month ago
Roivant Sciences LtdROIV
28Buy$47.00+39.80%Maintains
a month ago
Cabaletta Bio IncCABA
27Buy$16.00+887.65%Reiterates
a month ago
Protagonist Therapeutics IncPTGX
33Buy$170.00+24.74%Maintains
a month ago
Evolus IncEOLS
26Buy$13.00+80.06%Reiterates
2 months ago
Argenx SeARGX
43Buy$1,202.00+46.89%Maintains
2 months ago
Aeon Biopharma IncAEON
9Buy$1.20+424.02%Maintains
2 months ago
Rapport Therapeutics IncRAPP
4Buy$66.00+132.97%Maintains
2 months ago
Disc Medicine IncIRON
17Buy$120.00+115.29%Maintains
2 months ago
Outlook Therapeutics IncOTLK
20Hold$1.60+240.43%Maintains
3 months ago
Crinetics Pharmaceuticals IncCRNX
24Hold$85.00+0.06%Downgrades
3 months ago
Theravance Biopharma IncTBPH
17Hold$17.00-0.18%Downgrades
3 months ago
Neumora Therapeutics IncNMRA
8Buy$7.00+1,877.40%Maintains
4 months ago
Immunovant IncIMVT
23Buy$40.00+43.37%Maintains
5 months ago
Apellis Pharmaceuticals IncAPLS
29Hold$41.00-0.07%Downgrades
6 months ago
Viridian Therapeutics IncVRDN
17Buy$22.00+19.70%Maintains
6 months ago
Minerva Neurosciences IncNERV
16Hold$7.00+197.87%Maintains
7 months ago
Xenon Pharmaceuticals IncXENE
6Buy$74.00+118.29%Maintains
7 months ago
Arcutis Biotherapeutics IncARQT
5Buy$34.00+28.74%Maintains
8 months ago
Dare Bioscience IncDARE
18Buy$12.00+1,546.09%Reiterates
10 months ago
Alkermes PLCALKS
17Hold$46.00N/AReiterates
a year ago
EVO
10Buy$7.00N/AMaintains
a year ago
Sage Therapeutics IncSAGE
21Hold$12.00N/AReiterates
a year ago
Coherus Oncology IncCHRS
25Buy$7.00N/AReiterates
a year ago
Scpharmaceuticals IncSCPH
14Buy$18.00N/AReiterates
2 years ago
Trevena IncTRVN
10Hold$5.00N/ADowngrades
2 years ago
Marinus Pharmaceuticals IncMRNS
19Hold$2.00N/AReiterates
2 years ago
Revance Therapeutics IncRVNC
18Hold$6.60N/AReiterates
2 years ago
Cerevel Therapeutics Holdings IncCERE
6Hold$45.00N/ADowngrades
3 years ago
Rvl Pharmaceuticals PLCRVLPQ
3Buy$3.00N/AMaintains
3 years ago
Climb Bio IncCLYM
2Hold$6.00N/AReiterates
4 years ago
Amryt Pharma PLCAMYT
3HoldN/AN/ADowngrades
4 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$74.00N/AInitiates Coverage On
4 years ago
Therapeuticsmd IncTXMD
5Hold$10.00N/ADowngrades
4 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
4HoldN/AN/ADowngrades
4 years ago
Histogen IncHSTOQ
2Buy$30.00N/AMaintains
5 years ago
Radius Health IncRDUS1
5Hold$10.00N/AMaintains
5 years ago
Gw Pharmaceuticals PLCGWPH
3Hold$220.00N/ADowngrades
6 years ago
Amag Pharmaceuticals IncAMAG
2Hold$13.75N/ADowngrades
6 years ago
Momenta Pharmaceuticals IncMNTA
4Hold$52.50N/ADowngrades
6 years ago
Chiasma IncCHMA
2Buy$10.00N/AMaintains
7 years ago
Dermira IncDERM2
1Hold$18.75N/ADowngrades
7 years ago
Icon PLCICLR
3Hold$148.00N/AMaintains
8 years ago
Teva Pharmaceutical Industries LtdTEVA
5Hold$23.00N/AMaintains
8 years ago
Phibro Animal Health CorpPAHC
1Strong Sell$33.00N/AMaintains
8 years ago
Pfenex IncPFNX
1Strong Buy$8.00N/AMaintains
9 years ago
Endo International PLCENDPQ
1Hold$10.00N/AMaintains
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.